These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38007387)

  • 41. Frequency of antimicrobial-resistant bloodstream infections in 111 hospitals in Thailand, 2022.
    Tuamsuwan K; Chamawan P; Boonyarit P; Srisuphan V; Klaytong P; Rangsiwutisak C; Wannapinij P; Fongthong T; Stelling J; Turner P; Limmathurotsakul D
    J Infect; 2024 Oct; 89(4):106249. PubMed ID: 39173918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis.
    Droz N; Hsia Y; Ellis S; Dramowski A; Sharland M; Basmaci R
    Antimicrob Resist Infect Control; 2019; 8():207. PubMed ID: 31893041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020.
    Huang Y-C; Kuo S-C; Fang C-T; Lauderdale T-L
    Microbiol Spectr; 2024 Aug; 12(8):e0060824. PubMed ID: 38916365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
    Tian L; Zhang Z; Sun Z
    Antimicrob Resist Infect Control; 2019; 8():86. PubMed ID: 31161033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.
    Temkin E; Fallach N; Almagor J; Gladstone BP; Tacconelli E; Carmeli Y;
    Lancet Glob Health; 2018 Sep; 6(9):e969-e979. PubMed ID: 30103998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit.
    Morkel G; Bekker A; Marais BJ; Kirsten G; van Wyk J; Dramowski A
    Paediatr Int Child Health; 2014 May; 34(2):108-14. PubMed ID: 24621234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bloodstream infections and antimicrobial resistance of responsible pathogens in Ukraine: results of a multicenter study (2013-2015).
    Salmanov AG; Voronenko YV; Vozianov SO; Shunko YY; Mamenko MY; Verner OM; Mykhalchuk VM; Vydyborets SV; Shkorbotun VO; Beketova HV; Okhotnikova OM; Goryainova NV; Oshlianska OA; Laksha O; Bielova O; Shuba VY; Osadcha TM
    Wiad Lek; 2019; 72(11 cz 1):2069-2075. PubMed ID: 31860848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital.
    Sajedi Moghaddam S; Mamishi S; Pourakbari B; Mahmoudi S
    BMC Infect Dis; 2024 Apr; 24(1):373. PubMed ID: 38565980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia.
    Marchello CS; Dale AP; Pisharody S; Rubach MP; Crump JA
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
    Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P
    Crit Care; 2010; 14(3):R113. PubMed ID: 20546564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province].
    Zhuo CY; Guo YY; Liu NJ; Liu BM; Xiao SN; Zhang Y; Guo XC; Li DN; Tan SY; He NH; Mai Y; Guan J; Zhuo C
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):996-1001. PubMed ID: 33445846
    [No Abstract]   [Full Text] [Related]  

  • 56. Antimicrobial Susceptibility among Gram-Negative Isolates in Pediatric Patients in Europe from 2013-2018 Compared to 2004-2012: Results from the ATLAS Surveillance Study.
    Seifert H; von Linstow ML; Janssen H; Dowzicky M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106441. PubMed ID: 34547422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 58. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
    Cohen B; Liu J; Larson E
    J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.